565 related articles for article (PubMed ID: 19567440)
1. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.
Cahill KS; Chi JH; Day A; Claus EB
JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
[TBL] [Abstract][Full Text] [Related]
3. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
4. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein.
Fineberg SJ; Ahmadinia K; Oglesby M; Patel AA; Singh K
Spine (Phila Pa 1976); 2013 Jul; 38(15):1304-9. PubMed ID: 23462577
[TBL] [Abstract][Full Text] [Related]
5. Morbid obesity increases cost and complication rates in spinal arthrodesis.
Kalanithi PA; Arrigo R; Boakye M
Spine (Phila Pa 1976); 2012 May; 37(11):982-8. PubMed ID: 22037526
[TBL] [Abstract][Full Text] [Related]
6. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.
Williams BJ; Smith JS; Fu KM; Hamilton DK; Polly DW; Ames CP; Berven SH; Perra JH; Knapp DR; McCarthy RE; Shaffrey CI;
Spine (Phila Pa 1976); 2011 Sep; 36(20):1685-91. PubMed ID: 21897187
[TBL] [Abstract][Full Text] [Related]
7. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges.
Deyo RA; Ching A; Matsen L; Martin BI; Kreuter W; Jarvik JG; Angier H; Mirza SK
Spine (Phila Pa 1976); 2012 Feb; 37(3):222-30. PubMed ID: 21494195
[TBL] [Abstract][Full Text] [Related]
8. Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.
Goode AP; Richardson WJ; Schectman RM; Carey TS
Spine J; 2014 Sep; 14(9):2051-9. PubMed ID: 24321129
[TBL] [Abstract][Full Text] [Related]
9. Does bone morphogenetic protein change the operative nonunion rates in spine fusions?
Guppy KH; Paxton EW; Harris J; Alvarez J; Bernbeck J
Spine (Phila Pa 1976); 2014 Oct; 39(22):1831-9. PubMed ID: 25299166
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for dysphagia after anterior cervical fusion.
Singh K; Marquez-Lara A; Nandyala SV; Patel AA; Fineberg SJ
Spine (Phila Pa 1976); 2013 Oct; 38(21):1820-5. PubMed ID: 23873236
[TBL] [Abstract][Full Text] [Related]
11. Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011.
Marquez-Lara A; Nandyala SV; Fineberg SJ; Singh K
Spine (Phila Pa 1976); 2014 Mar; 39(6):476-81. PubMed ID: 24365907
[TBL] [Abstract][Full Text] [Related]
12. The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database.
Veeravagu A; Cole TS; Jiang B; Ratliff JK; Gidwani RA
Spine J; 2014 Dec; 14(12):2929-37. PubMed ID: 24842396
[TBL] [Abstract][Full Text] [Related]
13. Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.
Rumalla K; Yarbrough CK; Pugely AJ; Koester L; Dorward IG
J Neurosurg Spine; 2016 Oct; 25(4):500-508. PubMed ID: 27203810
[TBL] [Abstract][Full Text] [Related]
14. Acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins.
Yaremchuk KL; Toma MS; Somers ML; Peterson E
Laryngoscope; 2010 Oct; 120(10):1954-7. PubMed ID: 20824786
[TBL] [Abstract][Full Text] [Related]
15. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
16. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.
Martin BI; Lurie JD; Tosteson AN; Deyo RA; Farrokhi FR; Mirza SK
Spine J; 2015 Apr; 15(4):692-9. PubMed ID: 25523380
[TBL] [Abstract][Full Text] [Related]
17. Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.
Cole T; Veeravagu A; Jiang B; Ratliff JK
J Bone Joint Surg Am; 2014 Sep; 96(17):1409-16. PubMed ID: 25187578
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism after thoracic/thoracolumbar spinal fusion.
Gephart MG; Zygourakis CC; Arrigo RT; Kalanithi PS; Lad SP; Boakye M
World Neurosurg; 2012 Nov; 78(5):545-52. PubMed ID: 22381270
[TBL] [Abstract][Full Text] [Related]
19. Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients.
Guppy KH; Harris J; Chen J; Paxton EW; Alvarez J; Bernbeck J
J Neurosurg Spine; 2016 Apr; 24(4):556-64. PubMed ID: 26722955
[TBL] [Abstract][Full Text] [Related]
20. The Incidence of Durotomy and its Clinical and Economic Impact in Primary, Short-segment Lumbar Fusion: An Analysis of 17,232 Cases.
Buck JS; Yoon ST
Spine (Phila Pa 1976); 2015 Sep; 40(18):1444-50. PubMed ID: 26426713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
